Tcrcure Biopharma Corpis An International Biotechnology Company Dedicated To Developing Advanced Cancer Immunotherapiesthe Company Focuses On Controlling Tumor Progression And Aims To Convert Cancers Into Manageable Chronic Diseasestcrcure Engages In Various Biotechnology Servicesincluding High Throughput Antigen Specific Tcr Cloningindustry Scale Virus Productiont Cell Genetic Engineeringand Immune Cell Manufacturing Founded In 2016Tcrcure Has Expanded Its Operations With Facilities In Beijingchongqingand Guangdongthe Company Has Made Significant Strides In Its Researchincluding The Development Of A Tcr Screening Platform And The Initiation Of Clinical Trialstcrcure S Product Pipeline Features Several Immunotherapies Targeting Various Cancerssuch As Ovarianlungand Liver Cancersamong Othersthe Company Has Received Recognition For Its Innovative Contributions To The Biotechnology Fieldbeing Named One Of Thetop 50 Biotechnology Innovators In Chinaby Kpmg
